VEEV

More Gains For Stocks: Climbing a Wall of Worry

Stocks have posted strong gains over the past week, and are set to rise further (over the long-term) despite a wall of worry. The gains come on strong quarterly earnings results (from Artificial Intelligence stocks, in particular) and a resolution on the debt ceiling. There are so many great investment opportunities right now for patient and disciplined investors (both growth and income opportunities).

A Top Healthcare Industry Stock Worth Considering

Given the challenging macroeconomic backdrop (high inflation, recession looming), if you had to list the top characteristics you’d like to see in a stock market investment right now, it might include things like: high profit margins, no debt, tons of cash and a sticky client base that is economically non-cyclical. The healthcare stock we review in this report has all of those things, plus a very high revenue growth rate, a large total addressable market opportunity, a wide economic moat and basically no competition. Plus the shares have sold off significantly this year, thereby creating a more attractive entry point. This is NOT a dividend stock, but rather a very attractive long-term growth stock. Your future self may thank you profusely if you pick up a few shares now.

Life Sciences Cloud Software Company: Even More Attractive on the Recent Price Pullback

There is a large and growing demand for cloud-based software in the life sciences industry, and the company we review in this report is the clear market leader (with a lot of long-term upside). And despite a recent earnings beat and guidance raise (on top of its already rapidly growing business) the shares have recently sold off (as part of the broader market’s recent sell off of top growth stocks in general). We believe these factors have combined to create an attractive buying opportunity, and we share all the details in this report, including a review of the business, growth prospects, valuation and risks. If you are a long-term investor, these shares are worth considering for a spot in your portfolio.